Read + Share
Amedeo Smart
Independent Medical Education
de Oliveira MFP, Rocha BO, Duarte GV. PASI 100 response to secukinumab in primary failure to ustekinumab: analysis of cost-effectiveness among biological drugs. Int J Dermatol 2021;60:1165-1167.PMID: 33934333
Email
LinkedIn
Facebook
Twitter
Privacy Policy